Common | Jotup

Helbiz Announces Reverse Split, Changes Name to micromobility.com Inc., New Ticker Nasdaq: MCOM in Anticipation of Future M&A Activities

Retrieved on:

Thursday, March 30, 2023

Public Transport, Transportation, Transport, Travel, Transfer, Exercise, Common stock, Class, Multimedia, Continental, CUSIP, Book, Common, Retail, Security (finance)

Simultaneously with the rebranding, Helbiz, Inc. is announcing a reverse split of our class A common stock shares (“Common Stock”).

Key Points:

Simultaneously with the rebranding, Helbiz, Inc. is announcing a reverse split of our class A common stock shares (“Common Stock”).
The reverse stock split will be implemented with a ratio of 1-for-50 shares of our Common Stock, par value $0.00001.
The rights and privileges of the holders of shares of common stock will be substantially unaffected by the reverse stock split.
The Company’s transfer agent, Continental Stock Transfer & Trust Company (“Continental”), will serve as exchange agent for the reverse stock split.

Ault Alliance Announces Agreement to Sell $10.0 Million Stated Value of Convertible Preferred Stock

Retrieved on:

Wednesday, March 29, 2023

Professional Services, Other Professional Services, Technology, Cryptocurrency, Other Technology, Finance, Fintech, Common stock, Hypothec, Bangladesh Securities and Exchange Commission, Sale, NYSE, Common, Security (finance), Series

Ault Alliance, Inc. (NYSE American: AULT), a diversified holding company (“Ault Alliance” or the “Company”), today announced that it has entered into a securities purchase agreement with certain institutional investors to purchase an aggregate of 100,000 shares of preferred stock of the Company, consisting of (i) 83,000 shares of Series E Convertible Preferred Stock (the “Series E Preferred Stock”), (ii) 1,000 shares of Series F Convertible Preferred Stock (the “Series F Preferred Stock”) and (iii) 16,000 shares of Series G Convertible Preferred Stock (the “Series G Preferred Stock” and collectively, the “Preferred Shares”).

Key Points:

Ault Alliance, Inc. (NYSE American: AULT), a diversified holding company (“Ault Alliance” or the “Company”), today announced that it has entered into a securities purchase agreement with certain institutional investors to purchase an aggregate of 100,000 shares of preferred stock of the Company, consisting of (i) 83,000 shares of Series E Convertible Preferred Stock (the “Series E Preferred Stock”), (ii) 1,000 shares of Series F Convertible Preferred Stock (the “Series F Preferred Stock”) and (iii) 16,000 shares of Series G Convertible Preferred Stock (the “Series G Preferred Stock” and collectively, the “Preferred Shares”).
Each share of Series E Preferred Stock and Series F Preferred Stock has a purchase price of $100.00, equal to each such share’s stated value.
The Series E Preferred Stock and Series F Preferred Stock permits the holders thereof to vote together with the holders of the Company’s common stock on a proposal to effectuate a reverse stock split of the Common Stock.
The Series F Preferred Stock permits the holder to cast 100,000 votes per share of Series F Preferred Stock on such proposal, provided, that such votes must be cast in the same proportions as the shares of Common Stock, the Company’s existing Series B preferred stock and the Series E Preferred Stock are voted on that proposal (excluding any shares of Common Stock that are not voted on the proposal).

Coya Therapeutics, Inc. Provides Business Update and Reports FY 2022 Unaudited Financial Results

Retrieved on:

Wednesday, March 29, 2023

Coya Therapeutics, Inc. (Nasdaq: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics and cell therapies intended to enhance function of Regulatory T Cells (Tregs) function, today announced its financial results for fiscal year ended December 31, 2022, and provided a clinical and business update.

Key Points:

Coya Therapeutics, Inc. (Nasdaq: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics and cell therapies intended to enhance function of Regulatory T Cells (Tregs) function, today announced its financial results for fiscal year ended December 31, 2022, and provided a clinical and business update.
In March 2023, the Company announced positive results from a proof-of-concept, open-label academic clinical study of COYA 302 in Amyotrophic Lateral Sclerosis (ALS).
Most recently, we announced positive clinical data for COYA 302 for the treatment of ALS in a four-patient, investigator-initiated trial.
In addition, during the year ended December 31, 2022, Coya entered into a license agreement with ARScience Biotherapeutics, Inc.

KBS Signs 24,280 Square Feet in Leases with Five Tenants at 494,289 Square-Foot Class A Office Park in Salt Lake City, Utah

Retrieved on:

Tuesday, March 28, 2023

Its location offers tenants easy accessibility to I-215, I-15, and Salt Lake City International Airport.

Key Points:

Its location offers tenants easy accessibility to I-215, I-15, and Salt Lake City International Airport.
The office park is only minutes from a variety of ski resorts, including Snowbird, Alta, Brighton, Park City Mountain Resort and more.
“This unusual topography strongly positions this asset over all other office properties in the Salt Lake Valley,” says Helgeson.
“In addition, KBS’ ability to provide excellent service continues to facilitate lease renewals at this asset.”
Millrock Park is located at 6550 S. Millrock Drive in Holladay, Utah.

InventHelp Inventor Develops a Modified Identifying Beverage Can (RVS-166)

Retrieved on:

Wednesday, March 29, 2023

Drink, Multimedia, Common, Sale, Nightclub

PITTSBURGH, March 29, 2023 /PRNewswire/ -- "I have accidently drunken someone else's beverage thinking it was mine," said an inventor from Rancho Cucamonga, Calif., "so I invented PARTY CAN."

Key Points:

PITTSBURGH, March 29, 2023 /PRNewswire/ -- "I have accidently drunken someone else's beverage thinking it was mine," said an inventor from Rancho Cucamonga, Calif., "so I invented PARTY CAN."
The patent-pending invention allows individuals to more easily distinguish one beverage from another which can be beneficial at sporting events, parties, business gatherings or crowded bars.
It improves sanitary conditions by preventing the spread germs, colds, flues, and other diseases.
21-RVS-166, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext.

Luis de Guindos: Interview with Business Post

Retrieved on:

Thursday, March 30, 2023

Secondly, looking at the macroeconomic situation, there are no problems with respect to the competitiveness of European economies.

Key Points:

Secondly, looking at the macroeconomic situation, there are no problems with respect to the competitiveness of European economies.
For example, the balance of payments in Spain, Greece, Ireland, or Portugal are in a much better position.
It was a sort of whatever it takes in fiscal policy while monetary policy was very supportive too.
We have other difficulties now, but these can be addressed more easily than during the great financial crisis.
Are you more optimistic about Europe’s economic outlook than you were in the latter half of last year?
Nevertheless, growth numbers weren’t great, hovering around 1 per cent, while inflation was clearly more positive, especially headline inflation.
The question now is how the events in the US banking system and Credit Suisse will impact the euro area economy.
Over the next weeks and months, we need to assess whether they will give rise to an additional tightening of financing conditions.
So you are more optimistic about the inflationary environment, but things have changed with regards to financial stability?
Our impression is that they will lead to an additional tightening of credit standards in the euro area.
And perhaps this will feed through to the economy in terms of lower growth and lower inflation.
Do you have a time period within which you want to see that realistically happen?
We know it cannot be tomorrow, but it has to be within our projection horizon, which is a period of two years.
In the case of the US, Silicon Valley Bank had quite a unique business model.
*Ireland has seen an exit of domestic banks in recent years, and we are now down to two main pillar banks.
Because if you have for instance numerous players which are not very active or are weak, then that competition isn’t real.
*
My personal view is that the period of negative interest rates is over, at least in the medium term.

ManukaGuard Medical Grade Manuka Honey Nasal Spray Now Available at all Army & Air Force Exchange Service Locations

Retrieved on:

Tuesday, March 28, 2023

ManukaGuard has announced that its all-natural Medical Grade Manuka Honey Sinus Spray, a wellness product made from pure medical grade manuka honey, is now available to military families at Army & Air Force Exchange Service stores throughout the country and online.

Key Points:

ManukaGuard has announced that its all-natural Medical Grade Manuka Honey Sinus Spray, a wellness product made from pure medical grade manuka honey, is now available to military families at Army & Air Force Exchange Service stores throughout the country and online.
The Army & Air Force Exchange Service ( AAFES ) is the retailer in U.S. Army and Air Force installations worldwide.
Specifically, sinus nasal spray containing medical grade manuka honey from New Zealand, may help.
ManukaGuard produces a range of natural wellness products containing pure medical grade manuka honey, including its uniquely formulated nasal spray , a cough & throat syrup , pots of edible, medical grade manuka honey of varying strengths, and more.

Camfil Air Quality Professionals Explain the Role of Air Filters in Reducing Spread of Colds and Airborne Illnesses

Retrieved on:

Monday, March 27, 2023

Ventilation, Filtration, Weather, Sneeze, Coughs and sneezes spread diseases, Common, Risk, Marketing, Heating, ventilation, and air conditioning, Personal protective equipment

Colds are more likely to spread during the winter because immune systems are less efficient during colder weather and because more people congregate indoors for longer periods, allowing airborne pathogens to spread via stagnant indoor air.

Key Points:

Colds are more likely to spread during the winter because immune systems are less efficient during colder weather and because more people congregate indoors for longer periods, allowing airborne pathogens to spread via stagnant indoor air.
In a new resource, air quality experts explain how ventilation and air filtration can be used to prevent the spread of airborne illnesses in indoor spaces, where they are most likely to spread.
,” says Mark Davidson, Manager of Marketing and Technical Materials at Camfil, “The right mix of ventilation, filtration, and air purifiers in a building can reduce the concentration of potentially harmful particles within indoor environments to improve air quality and reduce the risk of illnesses.”
How do airborne illnesses work?
How can you prevent airborne pathogens from spreading?

Mission Bio Joins NSF Cell Manufacturing Research Initiative to Advance Cell Therapy Development

Retrieved on:

Tuesday, March 28, 2023

SOUTH SAN FRANCISCO, Calif., March 28, 2023 /PRNewswire/ -- Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, has joined the National Science Foundation (NSF) Engineering Research Center for Cell Manufacturing Technologies (CMaT), leveraging its Tapestri® Platform to improve analytical assays and cell manufacturing processes. CMaT is a consortium of universities, companies, and clinical collaborators brought together to develop transformative tools and technologies for the consistent, scalable, and low-cost production of high-quality living therapeutic cells.

Key Points:

SOUTH SAN FRANCISCO, Calif., March 28, 2023 /PRNewswire/ -- Mission Bio , the pioneer in high-throughput single-cell DNA and multi-omics analysis, has joined the National Science Foundation (NSF) Engineering Research Center for Cell Manufacturing Technologies (CMaT), leveraging its Tapestri® Platform to improve analytical assays and cell manufacturing processes.
Consortium researchers will utilize Tapestri®'s single-cell multi-omics capabilities to streamline and improve analytical assays that are crucial for assessing quality during various stages of the cell therapy development process.
Because Tapestri® enables measurement of genotypic and immunophenotypic attributes at single-cell resolution, it will be particularly useful for early cell therapy development to validate cell engineering techniques.
"We're proud to join this collaborative effort across various sectors to advance the field of cell therapy from within the community," said Anjali Pradhan, Senior Vice President of Product Management and Marketing at Mission Bio.

CULT Food Science Announces Binding Letter of Intent to Acquire "Because Animals" Consumer Brands and Formulations

Retrieved on:

Tuesday, March 28, 2023

CULT, Taste, Vendor, Food, CSE, Animal, MI, Life, Agriculture, Carbon, FRA, USD, Common, Tim Draper, LOI, Suspended Animation, Inc, SOSV, Biodiversity, Climate change, Asset, Acquisition, Dog, Food chain, OTC, Pet, Climate, Letter, VC, Water resources, Orkla, Cat, Bank

Commercial pet food is estimated to drive as much as a quarter of the environmental impact of the factory farming industry.

Key Points:

Commercial pet food is estimated to drive as much as a quarter of the environmental impact of the factory farming industry.
With the launch of pet foods into the multi-billion dollar pet food market to complement CULT Food Science product portfolio, this represents another step in the company's mission to bring cell-based innovation into everyday life.
Because Animals' original co-founder Joshua Errett has left the startup, and, with this acquisition, is continuing the development and commercialization of the Because Animals' consumer brand business under a different name within CULT Food Science.
Because Animals Inc. will continue to innovate in the pet food industry, not associated with CULT Food Science.